Cannabis ETFs stay on top of drug rescheduling news
Marijuana may soon be reclassified as a Schedule III drug, and the news has sent cannabis ETFs, ahem, higher. The Trump administration’s potentially friendlier stance on bud follows a similar initiative to downgrade the drug from its current schedule I status, which was ultimately vaporized during the Biden administration. The likely rescheduling would mean more…